Ampicillinβ-lactam antibiotic CAS# 69-52-3 |
2D Structure
- Tezampanel
Catalog No.:BCC1993
CAS No.:154652-83-2
- Noopept
Catalog No.:BCC1804
CAS No.:157115-85-0
- LY450108
Catalog No.:BCC1725
CAS No.:376594-67-1
- Perampanel
Catalog No.:BCC1847
CAS No.:380917-97-5
- Aniracetam
Catalog No.:BCC4219
CAS No.:72432-10-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 69-52-3 | SDF | Download SDF |
PubChem ID | 23663979 | Appearance | Powder |
Formula | C16H18N3NaO4S | M.Wt | 371.4 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | D-(-)-α-Aminobenzylpenicillin sodium salt | ||
Solubility | Soluble to 100 mM in water | ||
Chemical Name | (2S,5R,6R)-6-[[(2R)-2-Amino-2-pheny | ||
SMILES | [Na+].CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C([O-])=O | ||
Standard InChIKey | KLOHDWPABZXLGI-YWUHCJSESA-M | ||
Standard InChI | InChI=1S/C16H19N3O4S.Na/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8;/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23);/q;+1/p-1/t9-,10-,11+,14-;/m1./s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Antibiotic. Widely used selection reagent for transformed cells expressing β-lactamase. |
Ampicillin Dilution Calculator
Ampicillin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6925 mL | 13.4626 mL | 26.9251 mL | 53.8503 mL | 67.3129 mL |
5 mM | 0.5385 mL | 2.6925 mL | 5.385 mL | 10.7701 mL | 13.4626 mL |
10 mM | 0.2693 mL | 1.3463 mL | 2.6925 mL | 5.385 mL | 6.7313 mL |
50 mM | 0.0539 mL | 0.2693 mL | 0.5385 mL | 1.077 mL | 1.3463 mL |
100 mM | 0.0269 mL | 0.1346 mL | 0.2693 mL | 0.5385 mL | 0.6731 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
molecular genetics, bacteriology, tissue culture Inhibits cell-wall synthesis by interfering with peptidoglycan cross-linking working concentration for stringent plasmids is 20μg/ml working concentration for relaxed plasmids is 50μg/ml store at 4°C, warm to room temperature before using
- Chlorpromazine HCl
Catalog No.:BCC4460
CAS No.:69-09-0
- Quinacrine 2HCl
Catalog No.:BCC4709
CAS No.:69-05-6
- Uncarine A
Catalog No.:BCN7767
CAS No.:6899-73-6
- Mulberrofuran A
Catalog No.:BCN3677
CAS No.:68978-04-1
- SKF 91488 dihydrochloride
Catalog No.:BCC6675
CAS No.:68941-21-9
- Kahweol
Catalog No.:BCC9006
CAS No.:6894-43-5
- H-D-Glu-OH
Catalog No.:BCC2936
CAS No.:6893-26-1
- Guaiacol salicylate
Catalog No.:BCC8327
CAS No.:87-16-1
- Eburicol
Catalog No.:BCN4252
CAS No.:6890-88-6
- Otonecine
Catalog No.:BCN2009
CAS No.:6887-34-9
- 8-O-Methylretusin-7-O-beta-D-glucopyranoside
Catalog No.:BCN7899
CAS No.:68862-13-5
- HMP Linker
Catalog No.:BCC2832
CAS No.:68858-21-9
- Penicillin G Sodium
Catalog No.:BCC4638
CAS No.:69-57-8
- D-Mannitol
Catalog No.:BCN2205
CAS No.:69-65-8
- Salicylic acid
Catalog No.:BCC4109
CAS No.:69-72-7
- Cytarabine hydrochloride
Catalog No.:BCC4116
CAS No.:69-74-9
- Maltose
Catalog No.:BCC8338
CAS No.:69-79-4
- 2,6-Dihydroxypurine
Catalog No.:BCN8476
CAS No.:69-89-6
- Hypaconitine
Catalog No.:BCN5988
CAS No.:6900-87-4
- Lycodoline
Catalog No.:BCN2506
CAS No.:6900-92-1
- Norchelerythrine
Catalog No.:BCN3643
CAS No.:6900-99-8
- Toltrazuril
Catalog No.:BCC4870
CAS No.:69004-03-1
- Toltrazuril sulfone
Catalog No.:BCC2008
CAS No.:69004-04-2
- Tiotidine
Catalog No.:BCC5676
CAS No.:69014-14-8
Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.[Pubmed:28285049]
J Colloid Interface Sci. 2017 Jul 1;497:217-225.
In this work the adsorption and the release of Ampicillin - a beta-lactam penicillin-like antibiotic - from MCM-41, SBA-15, and (amino functionalized) SBA-15-NH2 ordered mesoporous silica (OMS) materials were investigated. The silica matrices differ for their pore size (SBA-15 vs. MCM-41) mainly, and also for surface charge (SBA-15 and MCM-41, vs. SBA-15-NH2). OMS samples were characterized through small-angle X-rays scattering (SAXS), transmission electron microscopy (TEM), N2 adsorption-desorption isotherms, Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), and potentiometric titrations. The quantification of immobilized and released Ampicillin was monitored by mean of UV-Vis spectroscopy. Experimental adsorption isotherms evidenced that Ampicillin's loading is not related to the pore size (dBJH) of the adsorbent. Indeed the maximal loadings were 237mg/g for SBA-15 (dBJH=6.5nm), 278mg/g for MCM-41 (dBJH=2.2nm), and 333mg/g for SBA-15-NH2 (dBJH=5.6nm). Loading seems, instead, to be related to the surface charge density (sigma) of the sorbent surface. Indeed, at pH 7.4 Ampicillin drug is negatively charged and likely prefers to interact with SBA-15-NH2 (sigmaSBA-15-NH2=+0.223Cm(-2)) rather than the slightly negatively charged silicas (sigmaSBA-15=-0.044Cm(-2) and sigmaMCM-41=-0.033Cm(-2)). Similarly, Ampicillin release is affected by interfacial interactions. Indeed, we found a burst release from pure silica samples (SBA-15 and MCM-41), whereas a sustained one from SBA-15-NH2 sample. We explain this behavior as a result of an attractive interaction between the protonated amino group of SBA-15-NH2 and the negatively charged carboxylate group of Ampicillin. In summary, in order to obtain a sustained drug release, the chemical nature of the matrix's surface plays a role which is more important than its textural features. SBA-15-NH2 matrix is hence a suitable candidate for local sustained release of antibiotic drugs.
Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.[Pubmed:28320712]
Antimicrob Agents Chemother. 2017 May 24;61(6). pii: AAC.02489-16.
We first assessed telavancin (TLV) pharmacokinetics in rats after a single subcutaneous dose of 35 mg/kg of body weight. The pharmacokinetic data were used to predict a TLV dose that simulates human exposure, and the efficacy of TLV was then evaluated using a TLV dose of 21 mg/kg every 12 h against Enterococcus faecalis OG1RF (TLV MIC of 0.06 mug/ml) in a rat endocarditis model with an indwelling catheter. Therapy was given for 3 days with TLV, daptomycin (DAP), or Ampicillin (AMP) monotherapy and with combinations of TLV plus AMP, AMP plus gentamicin (GEN), and AMP plus ceftriaxone (CRO); rats were sacrificed 24 h after the last dose. Antibiotics were given to simulate clinically relevant concentrations or as used in other studies. TLV treatment resulted in a significant decrease in bacterial burden (CFU per gram) in vegetations from 6.0 log10 at time 0 to 3.1 log10 after 3 days of therapy. Bacterial burdens in vegetations were also significantly lower in the TLV-treated rats than in the AMP (P = 0.0009)- and AMP-plus-GEN (P = 0.035)-treated rats but were not significantly different from that of the AMP-plus-CRO-treated rats. Bacterial burdens from vegetations in TLV monotherapy and TLV-plus-AMP-and-DAP groups were similar to each other (P >/= 0.05). Our data suggest that further study of TLV as a therapeutic alternative for deep-seated infections caused by vancomycin-susceptible E. faecalis is warranted.
Indole-Induced Activities of beta-Lactamase and Efflux Pump Confer Ampicillin Resistance in Pseudomonas putida KT2440.[Pubmed:28352264]
Front Microbiol. 2017 Mar 14;8:433.
Indole, which is widespread in microbial communities, has received attention because of its effects on bacterial physiology. Pseudomonas putida and Pseudomonas aeruginosa can acquire Ampicillin (Amp) resistance during growth on indole-Amp agar. Transcriptome, mutant, and inhibitor studies have suggested that Amp resistance induced by indole can be attributed to increased gene expression of ttgAB encoding two genes of RND-type multidrug efflux operons and an ampC encoding beta-lactamase. Expression, enzyme activities, and mutational analyses indicated that AmpC beta-lactamase is important for acquiring Amp resistance of P. putida in the presence of indole. Here, we show, for the first time, that volatile indole increased Amp-resistant cells. Consistent with results of the volatile indole assay, a low concentration of indole in liquid culture promoted growth initially, but led to mutagenesis after indole was depleted, which could not be observed at high indole concentrations. Interestingly, ttgAB and ampC gene expression levels correlate with the concentration of indole, which might explain the low number of Amp-mutated cells in high indole concentrations. The expression levels of genes involved in mutagenesis, namely rpoS, recA, and mutS, were also modulated by indole. Our data indicates that indole reduces Amp-induced heterogeneity by promoting expression of TtgABC or MexAB-OprM efflux pumps and the indole-induced beta-lactamase in P. putida and P. aeruginosa.
Recurrent trimethoprim-sulfamethoxazole-induced aseptic meningitis with associated ampicillin-induced myoclonic twitches.[Pubmed:28291512]
Int J Clin Pharmacol Ther. 2017 Jul;55(7):627-629.
OBJECTIVE: To report a case of recurrent trimethoprim-sulfamethoxazole-induced aseptic meningitis with associated Ampicillin-induced myoclonic twitches. MATERIALS AND METHODS: The patient was investigated using cerebral computed tomography, magnetic resonance imaging, cerebrospinal fluid examination, and electroencephalography. Written informed consent was obtained from the patient for access to clinical files for research purposes and publication. RESULTS: We present a middle-aged woman with two recurrent episodes of aseptic meningitis after treatment with trimethoprim-sulfamethoxazole. Additionally, she developed myoclonic twitches as a rare side effect of Ampicillin. CONCLUSION: Aseptic meningitis is a rare adverse reaction to medications like antibiotics. The pathogenesis of trimethoprim-sulfamethoxazole-induced aseptic meningitis is not yet completely understood, but an immune-mediated hypersensitivity reaction is suspected. If patients with an antibiotic therapy due to a systemic or local infection present with severe headache, not only common diagnosis of a parainfectious headache, but also antibiotic-induced aseptic meningitis should be considered..